BackProQR Therapeutics N.V Overview
ProQR Therapeutics N.V

ProQR Therapeutics N.V Target Price

Where could PRQR trade next? Consensus target price: $3.

Get informed when a big investor buys or sells

+ Follow

Share Price

$1.86

Average Target Price

$3.0061.3% upside

1 analysts in the last 4 months

High: $3 | Low: $3

Analyst Recommendations

No recommendations in the last 4 months.

Revenue & Income Forecast

Analysts' Target Prices

DateAnalystPrice TargetCurrent Upside/Downside
2026-06-26Chardan CapitalKeay Nakae$361.3% upsideOpen
2024-03-14Loop Capital MarketsKeay Nakae$2.534.4% upsideOpen
2022-12-30Raymond JamesRaymond James Raymond James$5168.8% upsideOpen
2022-12-22Cantor FitzgeraldJennifer Kim$5168.8% upsideOpen
2022-08-12Chardan CapitalKeay Nakae$27.5% upsideOpen

ProQR Therapeutics N.V (PRQR) FAQ

ProQR Therapeutics N.V (PRQR) currently reports a target price of $3. Use the charts on this page to explore ProQR Therapeutics N.V's target price history and peer comparisons.

Analysts' average 12-month price target for ProQR Therapeutics N.V is $3, about 61.3% upside from the current share price of $1.86. That spread summarizes where covering analysts expect the stock could trade over the next year, not a guarantee. Review the individual firm targets on this page — a wide high-to-low range often means opinion is split.

Start with the current target price of $3, then check the historical chart for trend and the peer comparison chart for relative positioning. From there, open related valuation or income-statement pages for ProQR Therapeutics N.V, and consider following PRQR for alerts when major investors trade the stock.

ProQR Therapeutics N.V is classified in the Healthcare sector. On target price, it currently shows $3. Sector peers often share similar capital intensity and growth regimes, so relative rankings inside Healthcare are usually more informative than comparing PRQR with unrelated industries.